As global health threats continue to evolve rapidly, pharmaceutical leaders face mounting pressure to design development programs that can withstand volatility. From pandemics to geopolitical unrest ...

The U.S. Food and Drug Administration said on Friday that it has launched a new pilot program to speed up the review process for generic drugs that are tested and manufactured entirely in the United ...

Collaboration aims to accelerate the adoption of renewable energy and reduce greenhouse gas emissions within the pharmaceutical value chain. Schneider Electric to design and deliver global program, ...

Catalyst MedTech today announced the launch of its new Connect program, an initiative that brings together collaborators ...

AUGUSTA, Maine (WABI) - Members of The Coalition to Protect Health Care for Rural and Underserved Communities met at the State House Wednesday to ask lawmakers to support a bill they say will protect ...

Purdue University’s Lilly Scholars are hitting the ground running in their training to become the next generation of pharmaceutical manufacturing talent. Thanks to a $42.5 million collaboration ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

No adverse signs or brain lesions observed in any Ketamir-2-treated rats. MK-801 control group showed clear neurotoxicity, validating study design. A new wave of value and momentum stocks could be ...

Catalyst Pharmaceuticals (NASDAQ:CPRX) has authorized a new share repurchase program of up to $200M. The program allows for ...

The U.S. Food and Drug Administration said on Friday it has launched a new pilot program to speed up the review process for ...